Klaus Leth Mortensen

Environmental Study of Azole-Resistant <i>Aspergillus fumigatus</i> and Other Aspergilli in Austria, Denmark, and Spain

Klaus Leth Mortensen, Emilia Mellado, Cornelia Lass‐Flörl et al. · Antimicrobial Agents and Chemotherapy · 2010 · 234 citations · Full text

Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.

Jesper Damsgaard Gunst, Marie H. Pahus, Lena Hagelskjær Kristensen et al. · EClinicalMedicine · 2021 · 192 citations · Full text

Controlled Trial, Covid-19 Pandemic, Clinical Trials +6

Aspergillus Species and Other Molds in Respiratory Samples from Patients with Cystic Fibrosis: a Laboratory-Based Study with Focus on Aspergillus fumigatus Azole Resistance

Klaus Leth Mortensen, Rasmus Krøger Hare, Helle Krogh Johansen et al. · Journal of Clinical Microbiology · 2011 · 175 citations · Full text

Diagnostic Mycology, Other Molds, Fungal Diversity +11

Development of Azole Resistance in Aspergillus fumigatus during Azole Therapy Associated with Change in Virulence

Maiken Cavling Arendrup, Eleftheria Mavridou, Klaus Leth Mortensen et al. · PLoS ONE · 2010 · 173 citations · Full text

Antifungal Agent, Azole Resistance, Aspergillus Fumigatus +13

Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM

Matteo Bassetti, Daniele Roberto Giacobbe, Christina Agvald‐Öhman et al. · Intensive Care Medicine · 2024 · 137 citations · Full text